Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Elena Omati"'
Autor:
Elena Omati, Emanuela Oggionni, Renata Nozza, Mary Cabiddu, Fausto Petrelli, Cinzia Scolari, Emanuela Alessandra Castelli, Gianluca Perego
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(4)
Olaparib is a first-in-class PARP inhibitor that has demonstrated efficacy as maintenance therapy in patients with ovarian cancer. It has been approved as a capsule formulation and after the publication of data from SOLO2 study became available also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4f40d828457a3b93c1265001001bdff
https://pubmed.ncbi.nlm.nih.gov/32041467
https://pubmed.ncbi.nlm.nih.gov/32041467
